MediMabBio is committed to advancing innovative immune therapeutics through a flexible and collaborative partnering approach. We actively seek opportunities for out-licensing, co-development, platform collaborations, and strategic research partnerships to accelerate the translation of our science into transformative medicines.
BD@medimabbio.com